ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Sustained Expression of CD39 Protects Acutely from Renal IRI but Promotes Fibrosis

V. Roberts, B. Lu, P. Cowan, S. Robson, K. Dwyer

Immunology Research Centre, St Vincent's Hospital, Melbourne, Victoria, Australia
University of Melbourne, Melbourne, Victoria, Australia
Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA

Meeting: 2013 American Transplant Congress

Abstract number: C1206

Background: The adenosinergic axis is involved in renal ischemia reperfusion injury (IRI) and the generation of adenosine by the action of CD39 and CD73 is protective. However, chronic elevation of adenosine has been linked to the development of renal fibrosis.

Aim: To access the effect of sustained versus transient increase in CD39 activity at 24 hours and week 4 post IRI

Methods: CD39 over-expressing (CD39Tg) mice and wild type (WT) littermates were subjected to unilateral renal ischemia for 23.5 min at 37°C. In a separate experiment, C57BL6 WT mice were treated with vehicle or apyrase 30 minutes prior to ischemia. Mice were euthanised at 24 hours or week 4 post-reperfusion and serum creatinine (Cr) and kidneys were assessed. At 24 hours, tubular injury was measured by blinded assessment of sections stained with H&E, using a semi-quantitative score of 0-5. At week 4, the degree of fibrosis was measured by computer-assisted analysis of sections stained with Masson’s trichrome.

Results: At 24 hours, CD39Tg mice and apyrase-treated WT mice had significantly lower Cr and less tubular injury than WT littermates and vehicle-treated WT controls, respectively.

By week 4, CD39Tg mice had significantly more fibrosis than WT littermates, but apyrase-treated WT mice had significantly less fibrosis than vehicle-treated WT mice. Creatinine levels were no different between the groups.

Conclusion: Acute protection from IRI may not always translate to better long term outcomes. Over-expression of CD39 or treatment with apyrase protects the kidney acutely from IRI, but sustained exposure to high CD39 promotes the development of fibrosis.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Roberts V, Lu B, Cowan P, Robson S, Dwyer K. Sustained Expression of CD39 Protects Acutely from Renal IRI but Promotes Fibrosis [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/sustained-expression-of-cd39-protects-acutely-from-renal-iri-but-promotes-fibrosis/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences